EP2704721
Pýrúvatkínasavirkjar til notkunar í meðferð
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
3.5.2012EP published:
11.4.2018EP application number:
12722013.5
EP translation filed:
3.7.2018Grant published:
15.8.2018EPO information:
European Patent Register
Max expiry date:
2.5.2032Expiry date:
2.5.2026Next due date:
31.5.2026
Title:
PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY
Timeline
Today
3.5.2012EP application
11.4.2018EP Publication
3.7.2018Translation submitted
15.8.2018Registration published
2.5.2026Expires
Owner
Name:
Agios Pharmaceuticals, Inc.Address:
88 Sidney Street, 02139, Cambridge, MA, US
Inventor
Name:
SU, Shin-San MichaelAddress:
Boston, MA, US
Name:
DANG, LennyAddress:
Boston, MA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201161482171 PDate:
3.5.2011Country:
US
Classification
Categories:
A61K 31/4965, A61K 31/497, A61P 7/06
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 15.5.2018
Expires: 2.5.2019
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 8
Paid: 23.4.2019
Expires: 2.5.2020
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 20.4.2020
Expires: 2.5.2021
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 20.4.2021
Expires: 2.5.2022
Payer: Sigurjónsson & Thor ehf.
Number: 11
Paid: 19.4.2022
Expires: 2.5.2023
Payer: Patice ehf.
Number: 12
Paid: 22.4.2023
Expires: 2.5.2024
Payer: Árnason Faktor ehf.
Number: 13
Paid: 18.4.2024
Expires: 2.5.2025
Payer: Árnason Faktor ehf.
Number: 14
Paid: 5.5.2025
Expires: 2.5.2026
Payer: Árnason Faktor ehf.